It is feasible to flag 'near end-of-life' status in older patients from routine general practice data. by Cardona, M et al.
RESEARCH
752 | REPRINTED FROM AJGP VOL. 49, NO. 11, NOVEMBER 2020 © The Royal Australian College of General Practitioners 2020
Magnolia Cardona, Margaret Williamson, 
Mark Jones, Danielle Ní Chróinín, 
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Background and objective
Prognostic uncertainty delays discussions 
and leads to unnecessary treatments for 
older patients who are dying. The aim of 
this study was to investigate the feasibility 
of using routinely collected data from 
MedicineInsight, a large Australian 
general practice database, to flag 
indicators of near end-of-life (nEOL) in 
patients aged ≥75 years and evaluate their 
association with death over 12 months.
Methods
A retrospective chart review was used to 
assess the feasibility of identifying these 
indicators in the data (160,897 patients 
from 464 practices across Australia). 
Conditional logistic regression was used 
to assess the independent contribution of 
nEOL indicators in patients aged 75–84 
and ≥85 years using a case-control 
design matching by practice.
Results
The strongest indicators for nEOL status 
were advanced malignancy, residential 
aged care, nutritional vulnerability, 
anaemia, cognitive impairment and heart 
failure. Other indicators included hospital 
attendance, pneumonia, decubitus ulcer, 
chronic obstructive pulmonary disease, 
antipsychotic prescription, male sex 
and stroke.
Discussion
Consideration of routinely collected 
patient data may suggest nEOL status 
and trigger advance care planning 
discussions.
THE PROPORTION OF PEOPLE aged ≥80 
years is predicted to increase by more 
than five times worldwide by 2050.1 In 
Australia, the proportion of individuals 
aged ≥75 years is expected to increase to 
10.4% in the same period.2
The rates of older patients using 
ambulances, emergency departments 
and acute hospitals in the last year of 
life are increasing.3–6 Some of these 
hospital presentations may be avoided, 
but end-of-life (EOL) conversations are 
often delayed until a health crisis arises.7 
Proactive identification of patients in the 
near-EOL (nEOL) stage in the primary 
care setting may reduce presentations 
to acute hospitals.8,9 Likewise, advance 
health directives, which are relatively 
rare (14%) in Australia,10 may help curb 
avoidable hospital transfers and better 
align admissions with patient goals of 
care. Factors contributing to delays in 
discussing and planning terminal care 
in the general practice setting include 
prognostic uncertainty, lack of time, 
non-reimbursement and perceived 
difficulty in choosing the right time 
for these conversations.11,12
These authors previously developed 
and tested nEOL indicators for older 
hospital patients (aged ≥65 years).13 In the 
community setting, there is currently no 
readily available screening tool to assist 
general practitioners (GPs) in identifying 
patients who may be nEOL. Automatic 
extraction from general practice clinical 
data systems potentially offers a structured 
way to identify risk factors that indicate 
nEOL, which may improve the GPs’ 
engagement in initiating advance care 
planning and shared decision making.
The aim of this study was to 1) assess 
the feasibility of using an existing 
Australian general practice database, 
MedicineInsight, to identify potential 
indicators of nEOL in patients aged 
≥75 years, and 2) to evaluate the 
association between the proposed nEOL 
indicators and death over the ensuing 
12 months for patients in general practice.
Methods
A retrospective chart review design 
(Study 1: Feasibility) was used to assess the 
feasibility of identifying these indicators 
using MedicineInsight data routinely 
extracted from several hundred Australian 
general practices, and a subsequent 
retrospective case-control study (Study 2: 
Associations with nEOL) evaluated the 
association between these indicators and 
death for patients aged ≥75 years.
General practice data from the 
MedicineInsight database, managed by 
NPS MedicineWise to support quality 
improvement in Australian primary care 
and post-market surveillance of medicines, 
were used for this study. These sentinel 
surveillance data were considered fit for 
purpose as they comprise anonymised 
practice representation from every state 
and territory; are compatible with the two 
major medical software packages used by 
Australian GPs; and allow text data mining 
from date fields, numeric fields and 
free-form text fields, which contributes 
to documenting the pre-specified 
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definitions (Appendix 1, available online 
only) without the use of numeric coding. 
Syntax from the statistical package SAS 
previously used in the same data source14 
to identify keywords related to patient 
clinical profiles and activities at the 
general practice encounter was modified 
to meet the needs of the present project. 
The data contain anonymised patient 
demographic and clinical data extracted 
directly from the clinical information 
systems of 464 general practices across 
all Australian states and territories. 
Items extracted from patient encounters 
include medical history (diagnoses/
conditions), prescriptions, investigations, 
pathology test results, observations, 
allergies and immunisations.15–17 Practices 
participating in the surveillance network 
have an opt-out system whereby individual 
patients have the right to refuse to their 
data being exported or used for research, 
and therefore their data are not used.
Study population
The study population for Study 1: Feasibility 
was all patients aged ≥75 years either living 
in the community or in residential aged 
care who had at least three encounters 
within two years with a GP at a practice 
participating in MedicineInsight between 
1 January 2014 and 31 December 2017. 
Patients were excluded if they had missing 
data on year of birth or sex, or their status 
was ‘inactive’ (ie they no longer attended 
the practice). Patients were assigned to the 
‘deceased’ group if they had a record of 
death recorded between 2014 and 2017, 
while patients with no record of death and 
whose status was active were assigned to 
the survivor group.
A case-control design (Study 2: 
Associations with nEOL) was implemented 
matching only by practice to account for the 
influence of the practice characteristics on 
death. Based on the achieved sample size, 
there was at least 80% power to detect an 
odds ratio of 1.3 or higher as statistically 
significant at the 1% level assuming a 
control rate of at least 10%. Cases were 
defined as all patients whose status was 
recorded as ‘died’ or where ‘died’ was 
recorded as a reason for encounter during 
2017 and the patient had no general 
practice encounters, prescriptions or tests 
following the status date. To maximise 
power,18,19 five controls for each case were 
randomly identified; these were matched 
by practice and included patients whose 
status was last recorded as ‘active’ and 
who had a least one activity (ie encounter, 
prescription or test) recorded at the 
general practice in 2017. Given evidence 
of heterogeneous indicators of death by 
age, the eligible patients were divided into 
two age groups: patients aged 75–84 years 
and patients ≥85 years. These strata were 
included as explanatory variables alongside 
sex in the predictive models.
Potential predictors of death in the 
short term
A list of potential predictors of death 
within 3–12 months for older patients 
in general practice was identified from a 
range of sources: studies of mortality risk 
in general practice;20–22 the Criteria for 
Screening and Triaging to Appropriate 
aLternative care (CriSTAL) tool,13 a 
hospital-based tool to predict short-term 
risk of death; and consultations with a 
geriatrician, medical and nursing aged 
care practitioners. Factors flagging 
nEOL status were extracted from 
MedicineInsight data fields using 
text-mining techniques. Most of the 
practices have automated result transfer 
from the pathology provider, so the 
result data were also in MedicineInsight 
database. To make the data elements 
comparable across different medical 
software packages, a set of rules was 
developed to define the different 
predictors or conditions, including 
a related list of synonyms, a list of 
medicines and pathology test result 
values (Appendix 1, available online only).
Statistical methods
To assess the feasibility of using 
MedicineInsight data to identify indicators 
associated with death and establish the 
completeness and usefulness of the data 
to flag these indicators, the researchers 
1) compared the prevalence of these 
indicators for all eligible patients in the 
study with their prevalence in available 
Australian population- or general practice–
based studies, and 2) identified which of 
the nEOL indicators were more prevalent 
in those patients who died between 2014 
and 2017 when compared with those who 
survived the entire study period.
Separate conditional logistic regression 
models for each age group (75–84 years 
and ≥85 years) were used to assess and 
quantify the association of each indicator 
with risk of death within 12 months 
using patients who died in 2017 and their 
matched controls. The decision to stratify 
by age group was based on previous 
knowledge that nEOL status for the very old 
(≥85 years) is mostly driven by factors such 
as frailty,23 whereas the risk of death in the 
short term for patients aged 75–84 years is 
driven by underlying comorbidities.24 All 
variables potentially associated with death 
(Appendix 1, available online only) were 
initially included in a multivariable model. 
Backwards stepwise elimination was used 
to remove statistically non-significant 
variables from the model based on a 
criterion of P >0.01, with the exception of 
age and sex, which remained in all models 
regardless of statistical significance because 
of well-established biological plausibility.
Explanatory variables included in the 
final multivariable model are reported 
as odds ratios, 95% confidence intervals 
and P values. This work was approved by 
the Royal Australian Collage of General 
Practitioners National Research & 
Evaluation Ethics Committee in February 
2018 [application MW01509].
Results
A total of 160,897 patients were identified 
to be eligible for Study 1: Feasibility 
(Appendix 2, available online only). Sixteen 
per cent of these patients (n = 25,891) had 
a record of death over the entire period, 
and 135,006 were active patients and 
assigned survivor status. For almost all the 
potential indicators, except for liver disease 
and holder of a healthcare card, patients 
who died had a higher prevalence of nEOL 
indicators than survivors, as reflected in 
the unadjusted odd ratios (Table 1). When 
the prevalence of the potential indicators 
of death was compared for all patients 
to available Australian data, the survivor 
group of MedicineInsight patients had 
a higher prevalence of atrial fibrillation 
or anticoagulant use, anaemia, chronic 
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Table 1. Prevalence (presence) of potential near end-of-life indicators in the study populations (Study 1 cohort)
Prevalence estimates (% Yes)
Other Australian 
prevalence data Eligible MedicineInsight patients aged ≥75 years 











SEIFA disadvantage 49.44 48.59 53.83 1.23 (1.20, 1.27)
Age >85 years 44.40 40.33 65.60 2.82 (2.74, 2.90)
Male sex 42.36 41.76 45.54 1.17 (1.14, 1.20)
Health Care Card holder 31.35 32.61 24.82 0.68 (0.66, 0.70)
Residential aged care facility resident 12.64 9.36 29.72 5.13 (4.96, 5.29)
Department of Veterans’ Affairs card holder 8.29 6.98 15.09 2.37 (2.27, 2.46)
Condition indicators
Chronic kidney disease (CKD) – moderate or severe 
or proteinuria (ever mentioned) or test results 
suggestive of CKD (previous 12 months)
25.2* (SAND 197)† 41.77 40.18 50.05 1.49 (1.45, 1.53)
Polypharmacy (≥7 current PBS medicines) – 28.97 26.38 42.49 2.06 (2.01, 2.12)
Atrial fibrillation (ever) or anticoagulant 
prescribed (previous 12 months)
18.0* (atrial fibrillation 
only; SAND 174)†
24.13 22.45 32.87 1.69 (1.64, 1.74)
Diabetes (ever mentioned) 16.7* (SAND 238)† 22.17 21.59 25.18 1.22 (1.18, 1.26)
Anaemia (previous 12 months) 16.0* (ABS)27 20.68 19.82 25.16 1.36 (1.32, 1.40)
COPD (ever mentioned) 12.7* (SAND 247)† 14.67 13.47 20.88 1.69 (1.64, 1.75)
Stroke (ever mentioned) 6.7* (ABS)28 14.04 12.71 21.01 1.83 (1.77, 1.89)
Heart failure (ever mentioned) 13.8* (SAND 236)† 13.74 11.05 27.77 3.10 (3.00, 3.20)
Antipsychotic prescribed (previous 12 months) – 11.66 9.66 22.08 2.65 (2.56, 2.74)
Cognitive impairment including dementia and 
intellectual handicap (ever mentioned)
17.1* (SAND 102)† 12.03 9.47 25.40 3.26 (3.15, 3.37)
Fall or fracture (previous six months) – 6.80 6.04 10.80 1.88 (1.80, 1.97)
Myocardial infarction (ever mentioned) 7.3* (acute coronary 
syndrome; SAND 188)†
6.02 5.47 8.91 1.69 (1.61, 1.78)
Chronic liver disease (ever mentioned) – 2.70 2.79 2.26 0.81 (0.74, 0.88)
Ulcer – decubitus or wound (previous 12 months) – 1.84 1.38 4.22 3.15 (2.92, 3.40)
Advanced malignancy (ever mentioned) 8.2* (ABS, malignant 
neoplasms)28
1.78 1.10 5.34 5.08 (4.72, 5.48)
Pneumonia (previous six months) 2.5‡ (SAND 179)† 1.67 1.24 3.89 3.22 (2.97, 3.48)
Nutritional vulnerability (previous 12 months)§ – 1.65 1.19 4.06 3.52 (3.25, 3.81)
Frailty – 0.48 0.36 1.10 3.06 (2.64, 3.54)
Depression (previous 12 months) – 0.47 0.41 0.80 1.96 (1.67, 2.30)
Health service indicators
Hospital attendance (previous 12 months) 18.2‖ (SAND 239)† 3.21 2.51 6.86 2.86 (2.70, 3.04)
ICU admission (previous 12 months) – 0.03 0.02 0.08 4.97 (2.69, 9.17)
*Age group ≥75 years
†Supplementary analysis of nominated data (SAND) are sub-studies of the annual Bettering the Evaluation and Care of Health (BEACH) survey29
‡Age group ≥50 years 
§Mention of appetite loss, malnutrition, supplementary feeding, feeding tube, unintentional weight loss, medicines or counselling/programs for weight loss
‖All ages
–, no comparator found in the Australian literature; ABS, Australian Bureau of Statistics; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICU, intensive care 
unit; PBS, Pharmaceutical Benefits Scheme; SAND, supplementary analysis of nominated data; SEIFA, Socioeconomic Index for Areas 
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kidney disease and stroke (Table 1). 
The prevalence of advanced malignancy, 
cognitive impairment, pneumonia (previous 
six months) and hospitalisation (previous 
12 months) was lower for the Study 1 
group than for other Australian data.
Independent risk factors for near 
end of life
For Study 2: Association with nEOL, 
two sub-samples were included. A total 
of 2287 cases and 11,435 matched 
controls aged 75–84 years met the 
eligibility criteria for analysis, as did 
4686 cases and 23,425 matched controls 
aged ≥85 years. Appendix 3 (available 
online only) compares the prevalence and 
unadjusted odds ratios of indicators for 
cases and matched controls in Study 2. 
Final models for both age groups suggest 
a similar group of variables associated 
with death within 12 months. Advanced 
malignancy, being in residential aged care, 
frailty, anaemia, nutritional vulnerability, 
cognitive impairment and heart failure 
were the strongest independent indicators 
for the younger age group. Other significant 
associations were hospital attendance in 
the past 12 months, pneumonia, decubitus 
ulcer, chronic obstructive pulmonary disease 
(COPD), prescription of antipsychotic 
medicines, myocardial infarction, male 
sex, ≥7 current Pharmaceutical Benefits 
Scheme medicines and stroke. Patients 
aged ≥85 years had a similar set of 
indicators, with the strongest predictors 
being advanced malignancy, residential 
aged care, nutritional vulnerability, 
anaemia and pneumonia (Table 2).
The model for patients aged ≥85 years 
included two additional variables: atrial 
fibrillation or anticoagulant prescribed, 
and diabetes. While only the younger 
patients’ model included the variables 
frailty, myocardial infarction and current 
polypharmacy, the odds ratios for the 
variables common to both age groups 
were generally greater for the younger 
group of patients when compared with 
the older group.
Discussion
To the authors’ knowledge, this is the first 
large-scale investigation of the ability of 
routinely extracted general practice data 
in Australia to identify potential indicators 
of nEOL status for older patients. The 
study supports the hypothesis that despite 
varying underreporting of some variables, 
MedicineInsight data routinely extracted 
from Australian general practices can 
be used to identify a set of potential 
indicators of nEOL for patients aged 
≥75 years. The strongest indicators 
for nEOL status for both groups were 
advanced malignancy, residential aged 
care, nutritional vulnerability, anaemia, 
cognitive impairment and heart failure. 
Other factors associated with increased 
likelihood of death by 12 months 
included hospital attendance, pneumonia, 
decubitus ulcer, COPD, antipsychotic 
prescription, male sex and stroke. The 
increased risk associated with each of 
these indicators varied between the two 
age groups.
Comparison with other studies
While a checklist of combined nEOL 
indicators is not routinely used in general 
practice, many of the independent 
risk factors for nEOL in the present 
study had been previously identified as 
predictors of death.20,21,25 The QMortality 
risk-prediction algorithm,21 developed 
in the UK, used an extensive list of >50 
baseline predictors from electronic 
medical records and >30 final validated 
demographic, clinical and social predictors 
of mortality. Although many of the clinical 
indicators overlap with those found in 
the present study, some social data items 
(such as ethnicity, living alone, loneliness) 
available in the UK are not recorded in 
extractable fields or are underreported in 
electronic clinical records in Australian 
general practices.
A recently published Australian 
case-control study of 215 deceased 
patients and 267 controls combined data 
from a chart audit of patients from three 
large general practices and data from a 
published randomised controlled trial of 
unguided intuition versus screening tools 
to identify risk of death.22 There was very 
little overlap between potential indicators 
collected in this study when compared 
with the present study. Many of the 
variables came from structured screening 
tools supplemented by general practice 
record audits. Only three independent 
variables overlapped with the present 
results for nutritional vulnerability, 
cognitive impairment and COPD: 
weight loss, neurological deterioration 
and advanced lung disease. However, 
the study is based on a very small 
sample of patients selected from those 
consenting to be part of a randomised 
controlled trial, and it used indicators 
that are not easily extracted from the 
clinical software. Others in Australia 
have proposed the use of the number of 
chronic diseases as a predictor of primary 
care encounters.26 For the present study, 
the researchers did not attempt the use 
of a summary measure of comorbidities 
as a predictor of death because it was 
more informative to personalise risk by 
identifying specific conditions.
Strengths and limitations of this study
This study uses MedicineInsight data, 
which provides a large and heterogeneous 
sample of participating general practices 
(representing approximately 10% 
of Australian general practices), GPs 
and patients located across the seven 
Australian states and territories. Where 
pathology results data were available, 
these enabled improved definitions 
of some of the potential indicators 
investigated. As management of patients 
may differ across practices, the researchers 
controlled for this potential confounder by 
matching those who died with survivors 
attending the same practice in the 
case-control study.
General practices participating in 
MedicineInsight were not randomly 
selected but are a convenience sample 
of practices so may not represent all 
Australian general practices. The low 
prevalence of advanced malignancy, 
cognitive impairment and pneumonia or 
hospitalisation in the preceding months 
when compared with other sources of 
Australian data27–29 suggests that these 
conditions may be underreported in the 
MedicineInsight data. It is not known 
whether the data gaps would tend to 
overestimate or underestimate the nEOL 
status. Although the researchers attempted 
to minimise misclassification bias using 
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the available data, it is likely that patients 
in the survivor (control) group may have 
died and information about their deaths 
was not available and/or recorded in 
the general practice data. To confirm 
the deceased status of all individuals 
and validate the findings by providing 
estimates of sensitivity, specificity and 
predictive values for likelihood of dying 
within 12 months, a further study linking 
the general practice data to national death 
registry data is needed. It is acknowledged 
that large sample sizes provide a more 
precise estimate but also increase the 
chances of finding a statistically significant 
result. The researchers chose a cut-off 
P value of 0.01 for inclusion of variables 
in the model to ensure only variables 
with strong evidence of association were 
retained in the model.
The completeness of information in 
these data is dependent on information 
provided by the patient, the clinician 
recording practices and the availability of 
that information being in designated data 
fields that are retrieved from the clinical 
information systems by MedicineInsight. 
Difficulties in obtaining comprehensive 
data to assist clinical decisions in primary 
care in Australia have been identified 
recently,30 highlighting a reduced 
capacity for large-scale meaningful 
translational research.
Conclusions and implications 
for practice
Considering the known underreporting of 
some of the MedicineInsight extractable 
fields, this study yields encouraging results 
about the potential for identifying nEOL 
status from routinely collected data from 
Table 2. Adjusted associations of near end-of-life by age group (Study 2 cohort)
Near end-of-life indicators on record Patients aged 75–84 years
(n = 13,722)
Patients aged ≥85 years
(n = 28,111)
Odds ratio
(95% CI) P value
Odds ratio
(95% CI) P value
Age 1.07 (1.04, 1.10) <0.0001 1.12 (1.11, 1.13) <0.0001
Advanced malignancy (ever mentioned) 7.59 (5.78, 9.96) <0.0001 4.57 (3.68, 5.68) <0.0001
Residential aged care resident 4.60 (3.88, 5.46) <0.0001 2.59 (2.38, 2.82) <0.0001
Frailty* 3.96 (1.85, 8.49) 0.0004
Anaemia (previous 12 months) 2.94 (2.62, 3.31) <0.0001 1.93 (1.79, 2.08) <0.0001
Nutritional vulnerability (previous 12 months) 2.77 (2.01, 3.82) <0.0001 2.05 (1.68, 2.50) <0.0001
Cognitive impairment (ever mentioned) 2.29 (1.95, 2.70) <0.0001 1.62 (1.48, 1.77) <0.0001
Heart failure (ever mentioned) 2.21 (1.91, 2.56) <0.0001 1.62 (1.49, 1.77) <0.0001
Hospital attendance (previous 12 months) 1.95 (1.51, 2.52) <0.0001 1.54 (1.32, 1.80) <0.0001
Pneumonia (previous six months) 1.93 (1.35, 2.75) 0.0003 1.72 (1.41, 2.10) <0.0001
Decubitus ulcer (previous 12 months) 1.70 (1.28, 2.25) 0.0003 1.61 (1.47, 1.77) <0.0001
COPD (ever mentioned) 1.69 (1.48, 1.93) <0.0001 1.37 (1.25, 1.50) <0.0001
Antipsychotic prescribed (previous 12 months) 1.49 (1.28, 1.74) <0.0001 1.45 (1.25, 1.69) <0.0001
Myocardial infarction (ever mentioned)* 1.38 (1.12, 1.69) 0.0020
Male sex 1.34 (1.20, 1.49) <0.0001 1.26 (1.17, 1.36) <0.0001
Polypharmacy (≥7 current PBS medicines)* 1.24 (1.10, 1.40) 0.0005
Stroke (ever mentioned) 1.23 (1.06, 1.43) 0.0053 1.23 (1.13, 1.34) <0.0001
Atrial fibrillation or anticoagulant prescribed (previous 
12 months)†
1.31 (1.21, 1.42) <0.0001
Diabetes† 1.16 (1.07, 1.26) 0.0005
*Only the younger patients’ model included the variables frailty, myocardial infarction and current polypharmacy.
†The model for patients aged ≥85 years included two additional variables: atrial fibrillation or anticoagulant prescribed, and diabetes.
CI, confidence interval; COPD, chronic obstructive pulmonary disease; PBS, Pharmaceutical Benefits Scheme
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older patients. This may be useful to 
assist clinicians in deciding when to start 
advance care planning discussions with 
older patients affected by progressive 
life-limiting illness. Widespread automated 
data extraction will save documentation 
time, and consistent and complete 
documentation of all relevant fields by 
GPs could enhance accuracy of prognostic 
factors. Early identification of patients 
potentially approaching the EOL stage 
before imminent dying begins is important 
but not sufficient. This needs to be followed 
by opportunities to clarify personal values 
and priorities around EOL, and ensure 
patients’ EOL wishes are incorporated into 
management plans. This is the first step 
in developing an algorithm to facilitate 
risk score calculations that could be 
incorporated in general practice clinical 
software to prompt advance care planning 
discussions with older high-risk patients. 
Several practical hurdles would need to 
be overcome to develop nEOL risk scores. 
This includes further research linking 
MedicineInsight data to national death 
data to confirm the survival status of every 
patient. This study also paves the way for a 
review of other interventions that may be 
informed by these estimates of nEOL risk.
The services provided by GPs, including 
the conduct of complex and successful 
discussions on EOL planning, may also be 
currently limited by a number of barriers 
including time and reimbursement. 
Acceptability of any intervention and the 
potential effect on real-world practice 
warrants further investigation.
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